Justin Johnson and Chad Rucker of valuations and fairness opinion provider VRC take a look at the regulator’s aims for continuation funds.
The Taiwan-based insurance company has backed a secondaries fund.
Although secondaries investors have limited influence on underlying assets, there are steps they can take to engage with ESG issues and promote science-based targets, says Tim Clare of Anthesis.
There is a shortage of buy-side capital for GP-led continuation funds, even though LPs are quickly waking up to the opportunity, say Portfolio Advisors’ Brian Mooney and Stephen Sloan.
The portfolio sale, relatively small compared to the $1bn-plus transactions that hit the market since last year, is expected to get a lot of looks.
With the rise in primary fundraising for sustainable investment, the manager of philanthropic and endowment capital sees the secondaries market following suit.
LPs face new risk management and execution issues as the GP-led secondaries market expands, say AltamarCAM Partners global CEO and managing partner José Luis Molina and partner Derek Snyder.
MetLife Investment Management has closed a $1.6bn fund seeded by a portfolio acquired off its own general account, part of a trend of insurers looking to become asset managers.
Leveraging global M&A execution capabilities and cross-functional knowledge is key to driving optimal pricing for GP-led deals, say PJT Partners managing directors Christopher Areson, Jolie Chow and Johanna Lottmann.
Konnin Tam, Steve Lessar and Veena Isaac were fired by BlackRock Monday morning to pre-empt their departure, just as the firm returned to market with a new secondaries fund.